522 Postmarket Surveillance Studies Database

The FDA has the authority to require device manufacturers to perform postmarket surveillance under Section 522 of the Food, Drugs and Cosmetics (FD&C) Act, when questions are identified for devices that meet the statutory criteria. This database contains information about 522 Postmarket Surveillance Studies that have been required. This database allows you to search information about the postmarket surveillance requirements by manufacturer or device.

Learn more...

To search for Manufacturer beginning with a specific letter, select that letter

A

B

C

D

E

F

G

H

I

J

L

M

N

O

P

R

S

T

U

V

W

X

Z

Clinical Study

General
Study Status	Consolidated
522 Number / Requirement Number	PS110033 / PSS001
Date Original Plan Accepted	08/16/2013
Date Current Plan Accepted	08/16/2013
Study Name	Clinical Study
Device Name	Revelation stem, model 427-21/42-080/180
Root Document Number	K083651
General Study Protocol Parameters
Study Design	Cross-Sectional Study
Data Source	New Data Collection
Comparison Group	Concurrent Control
Analysis Type	Analytical
Study Population	Adult: >21

Contact Us

---

Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources

---

• Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act, Guidance for Industry and Food and Drug Administration Staff
• 522 Program Background